Dr. Mehnaz Pervin is a postdoctoral researcher at the Baker Heart and Diabetes Institute, working in the Cardiovascular Inflammation and Redox Biology Laboratory. Her research focuses on understanding molecular mechanisms underlying inflammation, immune regulation, and cell death pathways, particularly in the context of diabetes and cardiovascular diseases. With a strong background in biochemistry, molecular biology, and immunology, she has contributed to advancing knowledge on NLRP3 inflammasome activation, pyroptosis, and inflammatory signalling, aiming to identify novel therapeutic targets that can limit tissue injury and promote cardiovascular health. Dr. Pervin has authored 17 scientific publications that have collectively received 547 citations, reflecting her growing influence in the biomedical research community. Her expertise spans inflammation biology, protein biochemistry, post-translational modifications, and translational research, supported by extensive experience in cellular and animal models of autoimmune and inflammatory diseases. She has demonstrated excellence in designing and executing complex experiments, performing data analysis, and integrating multidisciplinary approaches to address clinically relevant challenges. Dr. Pervin is recognized for her collaborative research ethos and scientific rigour, engaging in projects that bridge basic molecular insights with translational outcomes. Her contributions hold significant societal impact by advancing the development of targeted therapies for chronic inflammatory and metabolic disorders. Through her innovative approach, technical proficiency, and commitment to translational excellence, Dr. Pervin continues to contribute meaningfully to the global scientific community, fostering new directions in inflammation biology and cardiometabolic research.
Profiles: Scopus
Featured Publications
1. M. Pervin, “Targeting the NLRP3 Inflammasome-Gasdermin D Axis to Combat Cardiovascular Diseases,” Baker Heart and Diabetes Institute, Melbourne, Australia.
Dr. Mehnaz Pervin’s research advances scientific understanding of inflammation and immune regulation in cardiovascular and metabolic diseases, driving innovation toward targeted anti-inflammatory therapies. Her work contributes to improving global health outcomes by bridging molecular discoveries with translational applications that address major public health challenges.